Bronchiolitis obliterans: Outcome in the medium term.

Sardon O, Pérez-Yarza EG, Aldasoro A, Corcuera P, Mintegui J, Korta J.

An. Pediatr. 2012; 76: 58-64. FI: 0.770 (Q4).

ASP Investigator Grp. Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage.

Barberan J, Sanz F, Hernández JL, Merlos S, Malmierca E, García-Pérez FJ, Sánchez-Haya E, Segarra M, García de la Llana F, Granizo JJ, Giménez MJ, Aguilar L.

J. Infect. 2012; 65: 447-452. FI: 4.126 (Q1).

H1N1 SEMICYUC-CIBERES-REIPI. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza.

Díaz E, Martín-Loeches I, Canadell L, Vidaur L, Suarez D, Socias L, Estella A, Gil Rueda B, Guerrero JE, Valverdu-Vidal, M, Vergara, JC, López-Pueyo MJ, Magret M, Recio T, López D, Rello J, Rodríguez A.

J. Infect. 2012; 64: 311-318. FI: 4.126 (Q1).

Decline and Rise of the Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Middle Ear Fluid in Children: Influence of Changes in Circulating Serotypes.

Pérez-Trallero E, Marimón JM, Alonso M, Ercibengoa M, García-Arenzana JM.

Antimicrob. Agents Chemother. 2012; 56: 3989-3991. FI: 4.841 (Q1).

HTLV Spanish Study Grp. Development of Tropical Spastic Paraparesis in Human T-Lymphotropic Virus Type 1 Carriers Is Influenced by Interleukin 28B Gene Polymorphisms.

Treviño A, López, M, Vispo E, Aguilera A, Ramos JM, Benito R, Roc L, Eiros JM, De Mendoza C, Soriano V.

Clin. Infect. Dis. 2012; 55: 1-4. FI: 9.154 (Q1).

Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the results.

Ercibengoa M, Arostegi N, Marimón JM, Alonso M, Pérez-Trallero E.

BMC Infect. Dis. 2012; 12: -0. FI: 3.118 (Q2).

CIBERESP Cases Controls Pandemic. Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.

Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Martin V, Sáez M, Soldevila N, Quintana JM, Mayoral JM, Astray J, González-Candelas F, Cantón R, Tamames S, Castro A, Baricot M, Alonso J, Pumarola T.

Vaccine. 2012; 30: 5644-5650. FI: 3.766 (Q1).

Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection.

Borgatta B, Pérez M, Vidaur L, Lorente L, Socias L, Pozo JC, Garnacho-Montero J, Rello J.

Intensive Care Med. 2012; 38: 1152-1161. FI: 5.399 (Q1).

Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin.

Silva T, Abengozar MA, Fernández-Reyes M, Andreu D, Nazmi K, Bolscher JGM, Bastos M, Rivas L.

Amino Acids. 2012; 43: 2265-2277. FI: 3.248 (Q2).

Epidemiology of Invasive Pneumococcal Disease in Older People in Spain (2007-2009): Implications for Future Vaccination Strategies.

Ardanuy C, Marimón, JM, Calatayud L, Giménez M, Alonso M, Grau I, Pallares R, Pérez-Trallero E, Linares J.

PLoS One. 2012; 7: -0. FI: 4.092 (Q1).

ISAAC Phase Three Study Grp. Exposure to Cats and Dogs, and Symptoms of Asthma, Rhinoconjunctivitis, and Eczema.

Brunekreef B, Von Mutius E, Wong G, Odhiambo J, García-Marcos L, Foliaki S.

Epidemiology. 2012; 23: 742-750. FI: 5.566 (Q1).

Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates.

Vicente D, Esnal O, Pérez-Trallero E.

J. Infect. 2012; 64: 184-187. FI: 4.126 (Q1).

SISS. Genetic diversity of influenza A(H1N1)2009 virus circulating during the season 2010-2011 in Spain.

Ledesma J, Pozo F, Reina G, Blasco M, Rodríguez G, Montes M, López-Miragaya I, Salvador C, Reina J, Ortíz de Lejarazu R, Egido P, López Barba J, Delgado C, Cuevas MT, Casas I.

J. Clin. Virol. 2012; 53: 16-21. FI: 3.969 (Q2).

Impact of an asthma educational intervention programme on teachers.

Murua J, Korta, Pérez-Yarza EG, Pertega Díaz S, Aldasoro Ruiz A, Sardon Prado O, López-Silvarrey Varela A, Corcuera Elosegui P, Mintegui Aramburu FJ.

An. Pediatr. 2012; 77: 236-246. FI: 0.770 (Q4).